VerImmune
VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.
VerImmune is active in the biotechnology, health care, oncology, therapeutics space based in Greater Baltimore-Maryland Area, East Coast, Southern US, founded in 2020.
Within the biotechnology, health care, oncology, therapeutics space, the company focuses on its core offering rather than a broad product line.
Greater Baltimore-Maryland Area, East Coast, Southern US is where the company is located.
Its current recorded stage is Seed.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $6.5M in funding.
| Sector | Biotechnology, Health Care, Oncology, Therapeutics |
|---|---|
| Headquarters | Greater Baltimore-Maryland Area, East Coast, Southern US |
| Country | US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $6,480,844 |
Website: www.verimmune.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account